Differences in HIV-1 pol sequences from female genital tract and blood during antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 34, Issue 1, 2003, Pages 37-44

  De Pasquale, Maria Pia ^a   Brown, Andrew J Leigh ^b   Cu Uvin, Susan ^c   Allega Ingersoll, Jessica ^d   Caliendo, Angela M ^d   Sutton, Lorraine ^a   Donahue, Shannon ^c   D'Aquila, Richard T ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c BROWN UNIVERSITY   (United States)

^d EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Anatomic compartmentalization; Drug resistance; Female genital tract; HIV; Pol

Indexed keywords

EFAVIRENZ; INDINAVIR; LAMIVUDINE; NELFINAVIR; PROTEINASE; RITONAVIR; RNA DIRECTED DNA POLYMERASE; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE GENITAL SYSTEM; GENE MUTATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STRUCTURAL GENE; UTERINE ENDOCERVIX; VIRUS REPLICATION;

ADULT; ANTI-HIV AGENTS; CERVIX UTERI; DRUG RESISTANCE, VIRAL; FEMALE; GENES, POL; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MIDDLE AGED; MUTATION; PHYLOGENY; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; TREATMENT FAILURE; VAGINA; VIRAL LOAD;

EID: 0041412835     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200309010-00005     Document Type: Article

References (22)

1. Cu Uvin S, Caliendo AM, Reinert SE, et al. HIV-1 in the female genital tract and the effect of antiretroviral therapy. AIDS. 1998;12:826-827.
2. Cu-Uvin S, Caliendo AM, Reinert S, et al. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS. 2000;14:415-421.
3. Si-Mohamed A, Kazatchkine MD, Heard I, et al. Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy. J Infect Dis. 2000;182:112-122.
4. Di Stefano M, Fiore JR, Monno L, et al. Detection of multiple drug-resistance-associated pol mutations in cervicovaginal secretions from women largely treated with antiretroviral agents. AIDS. 1999;13:992-994.
5. Wainberg MA, Beaulieu R, Tsoukas C, et al. Detection of zidovudine-resistant variants of HIV-1 in genital fluids. AIDS. 1993;7:433-434.
6. Yerly S, Kaiser L, Race E, et al. Transmission of antiretroviral-drug-resistant HIV-1 variants. Lancet. 1999;354:729-733.
7. Johnson VA, Petropoulos CJ, Woods CR, et al. Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant. J Infect Dis. 2001;183:1688-1693.
8. Gupta P, Leroux C, Patterson BK, et al. Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral Quasi species between blood and semen. J Infect Dis. 2000;182:79-87.
9. Reichelderfer PS, Coombs RW, Wright DJ, et al. Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team. AIDS. 2000;14:2101-2107.
10. Cu-Uvin SHJ, Warren D, Klein RS, et al, for the HER Study Group. Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high risk HIV-seronegative women. Clin Infect Dis. 1999;29:1145-1150.
11. Keil W, Bachus J, Troger HD. Evaluation of MHS-5 in detecting seminal fluid in vaginal swabs. Int J Legal Med. 1996;108:186-190.
12. Martinez-Picado J, Sutton L, De Pasquale MP, et al. Human immunodeficiency virus type 1 cloning vectors for antiretroviral resistance testing. J Clin Microbiol. 1999;37:2943-2951.
13. Kumar S, Tamura K, Jakobsen IB, et al. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics. 2001;17:1244-1245.
14. Daar ES, Frost SDW, Wong JK, et al. Mixed infection with multidrug resistant and wild type HIV strains in primary HIV infection: early viral rebound suggests loss of immune control. Paper presented at: Ninth Conference on Retroviruses and Opportunistic Infections. Seattle, WA; February 24-28, 2002. Abstract #96.
15. Eron JJ, Vernazza PL, Johnston DM, et al. Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission. AIDS. 1998;12:F181-F189.
16. Byrn RA, Zhang D, Eyre R, et al. HIV-1 in semen: an isolated virus reservoir. Lancet. 1997;350:1141.
17. Kashuba ADM, Min SS, Corbett AH, Rezk N, Cohen MS. Comparison of Protease Inhibitor and Non-Nucleoside Reverse Transcriptase Inhibitor Concentrations in Male and Female Genital Tract. Journal of Investigative Medicine. 2003;51(2).
18. Taylor SBD, Drake SM, Workman J, et al. Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir. J Antimicrob Chemother. 2001;48:351-354.
19. Gunthard HF, Leigh-Brown AJ, D'Aquila RT, et al. Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol. Virology. 1999;259:154-165.
20. Ellerbrock TV, Lennox JL, Clancy KA, et al. Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretions. J Infect Dis. 2001;184:28-36.
21. Hart CE, Lennox JL, Pratt-Palmore M, et al. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis. 1999;179:871-882.
22. Farrar DJ, Cu Uvin S, Caliendo AM, et al. Detection of HIV-1 RNA in vaginal secretions of HIV-1-seropositive women who have undergone hysterectomy. AIDS. 1997;11:1296-1297.